The dataset contains predictor variables (baseline immune data, demographics, and transcriptomics) and outcome variables (vaccine responsiveness).
Figure 2. Overview of the baseline measurements included in the dataset.
Predictor variables
These variables comprise demographic characteristics (e.g., age, sex, ethnicity) and pre-vaccination immune features measured before vaccine administration (baseline).
v0_cd4 : Measure of cytokine production by CD4+ T cells in response to influenza antigens
v0_cd8 : Measure of cytokine production by CD8+ T cells in response to influenza antigens
Further classified by cytokines measured (ifng, il2) cells and the associated influenza strains (h3, hmnp, hab, bmnp)
ie. h1_v0_cd4_ifng, h3_v0_cd4_il2
Viral and Bacterial Load:
v0_resp_virus_positive: Presence of 14 different respiratory viruses (flu, adenoviruses, rhinoviruses, coronaviruses, etc.) detected via RT-PCR at baseline.
v0_pneumo_ng_log10copies_ul: Nasal Streptococcus pneumoniae density (log10 copies per µL).
These variables measure vaccine-induced immune responses across humoral, cellular, and mucosal immunity. Fold change corresponds to the magnitude change between measurements at baseline and measurements 21 days post-vaccination.
🧪 Humoral Responses
h1_hai_gmt_fold_change: Responsiveness in HAI titers for H1N1 (serum antibody response blocking virus-host interaction).
h3_hai_gmt_fold_change: Responsiveness in HAI titers for H3N2.
ph1n1_ha_iga_fold_change: Responsiveness in mucosal IgA binding to H1N1 hemagglutinin.
🧫 Cellular Responses
Fold change response variables for T-cell cytokine levels:
Classified by cytokines measured (ifng, il2) cells and the associated influenza strains (h1, h3, hmnp, hab, bmnp)
All CD4+ T cell fold change responses: h1_cd4_ifng_fold_change, h1_cd4_il2_fold_change, h3_cd4_ifng_fold_change, h3_cd4_il2_fold_change, hmnp_cd4_ifng_fold_change, hmnp_cd4_il2_fold_change, hab_cd4_ifng_fold_change, hab_cd4_il2_fold_change, bmnp_cd4_ifng_fold_change, bmnp_cd4_il2_fold_change
nc99_ivpm_h1_fold_change: Responsiveness in antibody binding to HA from A/New Caledonia/20/1999, measured using a high-throughput HA microarray platform which allows to test the presence of antibodies that can bind vaccine-formulated influenza strains and historical and drifted influenza strains not included in the vaccine formulation.
For more information about all variables contained in the Flu Fighters dataset, please see the Variable Legend